CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1 Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00990587
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:54.122648+00:00
Published At: 2015-06-22T00:00:00+00:00
Record Updated At: 2015-06-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hematologic Malignancy", "Acute Lymphocytic Leukemia", "Chronic Lymphocytic Leukemia", "Myelodysplasia", "Acute Myeloid Leukemia", "Chronic Myelogenous Leukemia", "Hodgkin\u0027s Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-06-22"
protocolSection.identificationModule.nctId: "NCT00990587"
protocolSection.identificationModule.officialTitle: "Phase 1 Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.